GlassScriptPhysician profile
Amy Suzanne Fiedler
NPI 1306211214
$1,738.49
in general payments reported to CMS, 2019-2025
13 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.06 · 2023: $331 · 2024: $1,028 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868 · Travel and Lodging: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.93 |
| Travel and Lodging | $809.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $838.59 | 2024-2025 | Cardiomems, Xact |
| Terumo Medical Corporation | $256.06 | 2021-2025 | Glidesheath Slender, Tr Band, Azur Cx Detachable |
| Boston Scientific Corporation | $170.37 | 2023 | Icefx Cryoablation System, Embold Fibered |
| Abbvie INC. | $123.98 | 2023 | |
| Galderma Laboratories, L.P. | $100.58 | 2024-2025 | Dysport |
| Bard Peripheral Vascular, INC. | $77.82 | 2024-2025 | Trek, Venovo |
| Eisai INC. | $39.33 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.41 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $24.65 | 2024 | Enhertu |
| Incyte Corporation | $24.62 | 2025 | Monjuvi, Pemazyre |
| Sobi, INC | $20.91 | 2024 | |
| Medtronic, INC. | $20.65 | 2025 | Concertotm |
| Daiichi Sankyo INC. | $15.52 | 2025 | Enhertu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Fiedler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.